Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
absorb, accessory, AFS, ANMAT, AONC, Argentina, Asian, aware, cadence, chaired, convened, cyber, cybersecurity, defense, disaggregated, dissatisfaction, driver, drop, Equiniti, extortion, fallen, feedback, fewer, fractional, hinder, HTM, incident, intelligence, judged, Kingdom, lot, MHRA, muscle, nearest, NIST, notifying, odd, Oncology, overseeing, phased, posture, premarket, promptly, ransom, reconciliation, reconciling, reduction, regain, retroactively, rounded, Sanitary, scrutiny, split, systematically, theft, threat, unabsorbed, unaffected, unrealized, vendor
Removed:
Andronico, auditor, avoid, clarify, communicating, domestically, East, economy, escalating, Europe, Famiglietti, fourth, globe, GSK, half, hamper, HIPAA, identification, identified, input, matter, Middle, milestone, Moody, ninety, outbreak, personalization, Placement, prioritization, relevance, remotely, Repurchase, retained, secured, serviced, transient, Underwriter, vaccination, Warrant, worked
Filing tables
Filing exhibits
Related press release
Associated NURO transcripts
NURO similar filings
Filing view
External links
Exhibit 32
CERTIFICATION
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of NeuroMetrix, Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:
The Annual Report for the year ended December 31, 2023 (the "Form 10-K") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 1, 2024 | /s/ SHAI N. GOZANI, M.D., PH.D. | |||||||
Shai N. Gozani, M.D., Ph.D. Chairman, President and Chief Executive Officer |
Date: March 1, 2024 | /s/ THOMAS T. HIGGINS | |||||||
Thomas T. Higgins Senior Vice President, Chief Financial Officer and Treasurer |